These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10362699)
1. Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice. Welikson RE; Buck SH; Patel JR; Moss RL; Vikstrom KL; Factor SM; Miyata S; Weinberger HD; Leinwand LA Am J Physiol; 1999 Jun; 276(6):H2148-58. PubMed ID: 10362699 [TBL] [Abstract][Full Text] [Related]
2. Cardiomyopathy-related mutation (A30V) in mouse cardiac troponin T divergently alters the magnitude of stretch activation in α- and β-myosin heavy chain fibers. Mickelson AV; Gollapudi SK; Chandra M Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H141-H149. PubMed ID: 27769999 [TBL] [Abstract][Full Text] [Related]
3. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production. Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055 [TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels. Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937 [TBL] [Abstract][Full Text] [Related]
5. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain. Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366 [TBL] [Abstract][Full Text] [Related]
6. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. Epstein ND Adv Exp Med Biol; 1998; 453():105-14; discussion 114-5. PubMed ID: 9889820 [TBL] [Abstract][Full Text] [Related]
7. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683 [TBL] [Abstract][Full Text] [Related]
8. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Kim SJ; Iizuka K; Kelly RA; Geng YJ; Bishop SP; Yang G; Kudej A; McConnell BK; Seidman CE; Seidman JG; Vatner SF Am J Physiol; 1999 May; 276(5):H1780-7. PubMed ID: 10330263 [TBL] [Abstract][Full Text] [Related]
9. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Vikstrom KL; Factor SM; Leinwand LA Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372 [TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice. Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035 [TBL] [Abstract][Full Text] [Related]
12. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice. Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902 [TBL] [Abstract][Full Text] [Related]
13. A murine model for hypertrophic cardiomyopathy. Vikstrom KL; Factor SM; Leinwand LA Z Kardiol; 1995; 84 Suppl 4():49-54. PubMed ID: 8585273 [TBL] [Abstract][Full Text] [Related]
14. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382 [TBL] [Abstract][Full Text] [Related]
15. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy. Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830 [TBL] [Abstract][Full Text] [Related]
16. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356 [TBL] [Abstract][Full Text] [Related]
17. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
18. Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain. Hardt SE; Geng YJ; Montagne O; Asai K; Hong C; Yang GP; Bishop SP; Kim SJ; Vatner DE; Seidman CE; Seidman JG; Homcy CJ; Vatner SF Circulation; 2002 Feb; 105(5):614-20. PubMed ID: 11827928 [TBL] [Abstract][Full Text] [Related]
19. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Sanbe A; Nelson D; Gulick J; Setser E; Osinska H; Wang X; Hewett TE; Klevitsky R; Hayes E; Warshaw DM; Robbins J Circ Res; 2000 Aug; 87(4):296-302. PubMed ID: 10948063 [TBL] [Abstract][Full Text] [Related]